Home › Ovarian Epithelial Carcinoma › Ohio › Dayton
Ovarian Epithelial Carcinoma clinical trials in Dayton, OH
3 studies for Ovarian Epithelial Carcinoma are looking for participants at sites in and around Dayton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
RecruitingPhase 2
- Kettering Medical Center /ID# 274365, Kettering · 5 mi away
AZD5335 vs. Mirvetuximab Soravtansine in FRα-high and AZD5335 vs. Chemotherapy in FRα-low Platinum-resistant Ovarian Cancer
RecruitingPhase 3
- Research Site, Dayton
Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)
RecruitingPhase 3
- Miami Valley Hospital South, Centerville · 9 mi away
Ovarian Epithelial Carcinoma trials in other cities
- Durham, NC8 studies
- Boston, MA8 studies
- Chicago, IL7 studies
- San Diego, CA7 studies
- New York City, NY7 studies
- Baltimore, MD6 studies
- Philadelphia, PA6 studies
- Houston, TX6 studies
- Cleveland, OH6 studies
- Los Angeles, CA5 studies
- Edison, NJ5 studies
- Minneapolis, MN5 studies
Other studies in Dayton
- Lung Cancer14 studies
- Non-Small Cell Lung Cancer13 studies
- Ovarian Cancer9 studies
- Steatotic Liver Disease8 studies
- Heart Failure8 studies
- Endometrial Cancer7 studies
- Prostate Cancer7 studies
- Cancer (all types)7 studies
- Melanoma7 studies
- Obesity7 studies
- Breast Cancer7 studies
- Ulcerative Colitis6 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.